Molecular mechanisms of estrogen action: selective ligands and receptor pharmacology.

PubWeight™: 1.14‹?› | Rank: Top 10%

🔗 View Article (PMID 11162936)

Published in J Steroid Biochem Mol Biol on November 30, 2000

Authors

B S Katzenellenbogen1, I Choi, R Delage-Mourroux, T R Ediger, P G Martini, M Montano, J Sun, K Weis, J A Katzenellenbogen

Author Affiliations

1: Department of Molecular and Integrative Physiology, University of Illinois and College of Medicine, 524 Burrill Hall, 407 S. Goodwin Avenue, 61801-3704, Urbana, IL, USA. katzenel@life.uiuc.edu

Articles citing this

17beta-Estradiol inhibits Ca2+-dependent homeostasis of airway surface liquid volume in human cystic fibrosis airway epithelia. J Clin Invest (2008) 1.32

Integrated Model of Chemical Perturbations of a Biological Pathway Using 18 In Vitro High-Throughput Screening Assays for the Estrogen Receptor. Toxicol Sci (2015) 1.21

New insights into the molecular mechanisms underlying effects of estrogen on cholesterol gallstone formation. Biochim Biophys Acta (2009) 1.13

Estrogen-related abnormalities in glomerulosclerosis-prone mice: reduced mesangial cell estrogen receptor expression and prosclerotic response to estrogens. Am J Pathol (2002) 1.12

Resveratrol and estradiol exert disparate effects on cell migration, cell surface actin structures, and focal adhesion assembly in MDA-MB-231 human breast cancer cells. Neoplasia (2005) 1.06

Quercetin, a flavonoid phytoestrogen, ameliorates experimental allergic encephalomyelitis by blocking IL-12 signaling through JAK-STAT pathway in T lymphocyte. J Clin Immunol (2004) 0.97

Unexpected hormonal activity of a catechol equine estrogen metabolite reveals reversible glutathione conjugation. Chem Res Toxicol (2010) 0.95

Systemic administration of diarylpropionitrile (DPN) or phytoestrogens does not affect anxiety-related behaviors in gonadally intact male rats. Horm Behav (2008) 0.95

Eccentric exercise activates novel transcriptional regulation of hypertrophic signaling pathways not affected by hormone changes. PLoS One (2010) 0.93

The dynamic structure of the estrogen receptor. J Amino Acids (2011) 0.92

Assessment of xenoestrogens using three distinct estrogen receptors and the zebrafish brain aromatase gene in a highly responsive glial cell system. Environ Health Perspect (2006) 0.90

Estrogen signalling and the metabolic syndrome: targeting the hepatic estrogen receptor alpha action. PLoS One (2013) 0.89

Selective and potent agonists for estrogen receptor beta derived from molecular refinements of salicylaldoximes. Eur J Med Chem (2011) 0.88

Density of GFAP-immunoreactive astrocytes is decreased in left hippocampi in major depressive disorder. Neuroscience (2015) 0.84

Chemical communication threatened by endocrine-disrupting chemicals. Environ Health Perspect (2004) 0.83

The role of p53 in cancer drug resistance and targeted chemotherapy. Oncotarget (2016) 0.79

Synthesis and evaluation of 17α-E-20-(heteroaryl)norpregn-1,3,5(10),20 tetraene-3,17β-diols [17α-(heteroaryl)vinyl estradiols] as ligands for the estrogen receptor-α ligand binding domain (ERα-LBD). Bioorg Med Chem Lett (2011) 0.79

Non-nuclear actions of estrogen: new targets for prevention and treatment of cardiovascular disease. Mol Interv (2002) 0.79

Estrogens regulate the expression of NHERF1 in normal colon during the reproductive cycle of Wistar rats. Histochem Cell Biol (2010) 0.78

Role of the PDZ-scaffold protein NHERF1/EBP50 in cancer biology: from signaling regulation to clinical relevance. Oncogene (2017) 0.77

What's new in estrogen receptor action in the female reproductive tract. J Mol Endocrinol (2016) 0.77

Genome-wide transcriptional regulation of estrogen receptor targets in fallopian tube cells and the role of selective estrogen receptor modulators. J Ovarian Res (2016) 0.76

Synthesis and functional analysis of novel bivalent estrogens. Steroids (2010) 0.76

Reproductive hormonal treatments for mood disorders in women. Dialogues Clin Neurosci (2002) 0.76

Estrogenic and Acetylcholinesterase-Enhancement Activity of a New Isoflavone, 7,2',4'-Trihydroxyisoflavone-4'-O-beta-D-Glucopyranoside from Crotalaria Sessililflora. Cytotechnology (2003) 0.75

What should be the upper age limit for reproduction? J Midlife Health (2013) 0.75

Selenophenes: Introducing a New Element into the Core of Non-Steroidal Estrogen Receptor Ligands. ChemMedChem (2016) 0.75

Neuroprotective effects of ginsenosides Rh1 and Rg2 on neuronal cells. Chin Med (2011) 0.75

Prediction of selective estrogen receptor beta agonist using open data and machine learning approach. Drug Des Devel Ther (2016) 0.75

Articles by these authors

The sequence of the human genome. Science (2001) 101.55

Exportin 1 (Crm1p) is an essential nuclear export factor. Cell (1997) 10.32

Culture and systems of thought: holistic versus analytic cognition. Psychol Rev (2001) 6.08

Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity. Cell (2001) 4.78

Phenol red in tissue culture media is a weak estrogen: implications concerning the study of estrogen-responsive cells in culture. Proc Natl Acad Sci U S A (1986) 4.51

Importin beta is a mitotic target of the small GTPase Ran in spindle assembly. Cell (2001) 4.23

Structure of importin-beta bound to the IBB domain of importin-alpha. Nature (1999) 4.05

Smoking cessation with and without assistance: a population-based analysis. Am J Prev Med (2000) 3.92

Pyrazole ligands: structure-affinity/activity relationships and estrogen receptor-alpha-selective agonists. J Med Chem (2000) 3.34

Estrogen receptor-beta potency-selective ligands: structure-activity relationship studies of diarylpropionitriles and their acetylene and polar analogues. J Med Chem (2001) 3.24

Biomarkers of oxidative stress study II: are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning? Free Radic Biol Med (2005) 3.13

Vitamin D3 up-regulated protein 1 mediates oxidative stress via suppressing the thioredoxin function. J Immunol (2000) 2.96

Nanostructured high-strength molybdenum alloys with unprecedented tensile ductility. Nat Mater (2013) 2.90

Molecular characterization and transcriptional analysis of type 8 capsule genes in Staphylococcus aureus. J Bacteriol (1997) 2.58

Clinical manifestations and diagnosis of acute pyrethroid poisoning. Arch Toxicol (1989) 2.50

The skeletal muscle calcium release channel: coupled O2 sensor and NO signaling functions. Cell (2000) 2.41

Altered ligand binding properties and enhanced stability of a constitutively active estrogen receptor: evidence that an open pocket conformation is required for ligand interaction. Biochemistry (1997) 2.32

Human immunodeficiency virus type 1 subtypes differ in disease progression. J Infect Dis (1999) 2.32

Heme mediates derepression of Maf recognition element through direct binding to transcription repressor Bach1. EMBO J (2001) 2.32

Disruption of CD40-CD40 ligand interactions results in an enhanced susceptibility to Leishmania amazonensis infection. Immunity (1996) 2.24

Metabolic flare: indicator of hormone responsiveness in advanced breast cancer. J Clin Oncol (2001) 2.20

Predictors of smoking cessation in U.S. adolescents. Am J Prev Med (1999) 2.09

IMPACT trial results should not change current standard of care of 100 days for cytomegalovirus prophylaxis. Am J Transplant (2010) 2.05

Importin-beta-like nuclear transport receptors. Genome Biol (2001) 2.03

Activation of HER4 by heparin-binding EGF-like growth factor stimulates chemotaxis but not proliferation. EMBO J (1997) 2.02

Further characterization of endometrial integrins during the menstrual cycle and in pregnancy. Fertil Steril (1994) 1.99

Smoking, air pollution, and the high rates of lung cancer in Shenyang, China. J Natl Cancer Inst (1989) 1.99

The direction of transport through the nuclear pore can be inverted. Proc Natl Acad Sci U S A (1999) 1.99

Mice lacking complex gangliosides develop Wallerian degeneration and myelination defects. Proc Natl Acad Sci U S A (1999) 1.95

Indoor radon and lung cancer in China. J Natl Cancer Inst (1990) 1.95

Novel ligands that function as selective estrogens or antiestrogens for estrogen receptor-alpha or estrogen receptor-beta. Endocrinology (1999) 1.93

Pseudomonas aeruginosa ExoS and ExoT. Rev Physiol Biochem Pharmacol (2004) 1.91

Reverse transcriptase in a clinical strain of Escherichia coli: production of branched RNA-linked msDNA. Science (1989) 1.89

A phospholipid acts as a chaperone in assembly of a membrane transport protein. J Biol Chem (1996) 1.89

Transformation of NIH 3T3 cells by HER3 or HER4 receptors requires the presence of HER1 or HER2. J Biol Chem (1996) 1.87

Effects of pyrethroid insecticides on subjects engaged in packaging pyrethroids. Br J Ind Med (1988) 1.87

Estrogen imprinting of the developing prostate gland is mediated through stromal estrogen receptor alpha: studies with alphaERKO and betaERKO mice. Cancer Res (2001) 1.84

Androgen deprivation induces selective outgrowth of aggressive hormone-refractory prostate cancer clones expressing distinct cellular and molecular properties not present in parental androgen-dependent cancer cells. Cancer J (2001) 1.82

The estradiol pharmacophore: ligand structure-estrogen receptor binding affinity relationships and a model for the receptor binding site. Steroids (1997) 1.80

An estrogen receptor-selective coregulator that potentiates the effectiveness of antiestrogens and represses the activity of estrogens. Proc Natl Acad Sci U S A (1999) 1.79

Local anesthesia for functional endoscopic sinus surgery employing small volumes of epinephrine-containing solutions of lidocaine produces profound hypotension. Acta Anaesthesiol Scand (2005) 1.77

Ras CAAX peptidomimetic FTI-277 selectively blocks oncogenic Ras signaling by inducing cytoplasmic accumulation of inactive Ras-Raf complexes. J Biol Chem (1995) 1.75

Long-term T cell memory requires the surface expression of self-peptide/major histocompatibility complex molecules. Proc Natl Acad Sci U S A (1998) 1.71

Estrogen receptor transcription and transactivation: Estrogen receptor alpha and estrogen receptor beta: regulation by selective estrogen receptor modulators and importance in breast cancer. Breast Cancer Res (2000) 1.69

Immunodetection of poly(A) binding protein II in the cell nucleus. Exp Cell Res (1994) 1.67

Photoaffinity labels for estrogen binding proteins of rat uterus. Biochemistry (1973) 1.67

ACAPs are arf6 GTPase-activating proteins that function in the cell periphery. J Cell Biol (2000) 1.66

RAN/TC4 mutants identify a common requirement for snRNP and protein import into the nucleus. J Cell Biol (1996) 1.66

High-dose/activation-associated tolerance: a mechanism for allograft tolerance. Transplantation (1997) 1.65

Evidence that phospholipase A2 activity is required for Golgi complex and trans Golgi network membrane tubulation. Proc Natl Acad Sci U S A (1998) 1.65

Role of CD4+ T cells in pathogenesis associated with Leishmania amazonensis infection. J Immunol (1997) 1.62

A short course of methylprednisolone immunosuppression inhibits both rejection and spontaneous acceptance of rat liver allografts. Transplantation (2001) 1.61

Prevalence of naturally occurring surface gene variants of hepatitis B virus in nonimmunized surface antigen-negative Chinese carriers. Hepatology (2001) 1.61

The Bacillus subtilis DinR binding site: redefinition of the consensus sequence. J Bacteriol (1998) 1.61

Selective regulation of apoptosis: the cytotoxic lymphocyte serpin proteinase inhibitor 9 protects against granzyme B-mediated apoptosis without perturbing the Fas cell death pathway. Mol Cell Biol (1998) 1.59

Molecular analysis of the coiled body. J Cell Sci Suppl (1995) 1.59

Endometrial progesterone receptors and markers of uterine receptivity in the window of implantation. Fertil Steril (1996) 1.58

Type 1 and type 2 cytokine regulation of macrophage endocytosis: differential activation by IL-4/IL-13 as opposed to IFN-gamma or IL-10. J Immunol (1999) 1.58

Breast cancer: PET imaging of estrogen receptors. Radiology (1988) 1.53

Identification of novel CHD1-associated collaborative alterations of genomic structure and functional assessment of CHD1 in prostate cancer. Oncogene (2011) 1.50

Conformational changes and coactivator recruitment by novel ligands for estrogen receptor-alpha and estrogen receptor-beta: correlations with biological character and distinct differences among SRC coactivator family members. Endocrinology (2000) 1.50

Characterization of HIV-1 vpr nuclear import: analysis of signals and pathways. J Cell Biol (1998) 1.50

Proteolytic degradation of tyrosine nitrated proteins. Arch Biochem Biophys (2000) 1.49

Positron emission tomographic assessment of "metabolic flare" to predict response of metastatic breast cancer to antiestrogen therapy. Eur J Nucl Med (1999) 1.49

Interleukin-8 and its receptor CXCR2 in the tumour microenvironment promote colon cancer growth, progression and metastasis. Br J Cancer (2012) 1.49

Hepatic radioembolization with Yttrium-90 glass microspheres for treatment of primary liver cancer. Chin Med J (Engl) (1999) 1.48

The cell type-specific expression of the murine IL-13 gene is regulated by GATA-3. J Immunol (2001) 1.47

Real-time measurements of DNA hybridization on microparticles with fluorescence resonance energy transfer. Anal Biochem (1999) 1.47

The dystrobrevin-binding protein 1 gene: features and networks. Mol Psychiatry (2008) 1.47

Cloning and characterization of hSRP1 gamma, a tissue-specific nuclear transport factor. Proc Natl Acad Sci U S A (1998) 1.46

Promising thermoelectric properties of commercial PEDOT:PSS materials and their bi2Te3 powder composites. ACS Appl Mater Interfaces (2010) 1.45

An electrogenic Na(+)-HCO(-)(3) cotransporter (NBC) with a novel COOH-terminus, cloned from rat brain. Am J Physiol Cell Physiol (2000) 1.44

Cloning, characterization, and chromosomal mapping of a human electroneutral Na(+)-driven Cl-HCO3 exchanger. J Biol Chem (2000) 1.43

Identification and characterization of proSAAS, a granin-like neuroendocrine peptide precursor that inhibits prohormone processing. J Neurosci (2000) 1.43

Arabidopsis RelA/SpoT homologs implicate (p)ppGpp in plant signaling. Proc Natl Acad Sci U S A (2000) 1.42

Biomarkers of oxidative stress study III. Effects of the nonsteroidal anti-inflammatory agents indomethacin and meclofenamic acid on measurements of oxidative products of lipids in CCl4 poisoning. Free Radic Biol Med (2005) 1.42

Loss of endothelial surface expression of E-selectin in a patient with recurrent infections. Blood (1999) 1.42

Tamoxifen antiestrogens. A comparison of the activity, pharmacokinetics, and metabolic activation of the cis and trans isomers of tamoxifen. J Steroid Biochem (1982) 1.41

A hemisphere array for non-invasive ultrasound brain therapy and surgery. Phys Med Biol (2000) 1.40

Purinergic inhibition of the epithelial Na+ transport via hydrolysis of PIP2. FASEB J (2004) 1.40

Estrogen and antiestrogen action in reproductive tissues and tumors. Recent Prog Horm Res (1979) 1.39

N-acetylcysteine induces cell cycle arrest in hepatic stellate cells through its reducing activity. J Biol Chem (2001) 1.39

Novel structural templates for estrogen-receptor ligands and prospects for combinatorial synthesis of estrogens. Chem Biol (1999) 1.39

Ran-independent nuclear import of cyclin B1-Cdc2 by importin beta. Proc Natl Acad Sci U S A (1999) 1.39

Endoscopic versus operative gastrostomy: final results of a prospective randomized trial. Gastrointest Endosc (1990) 1.39

Effect of liver transplantation on islet allografts: up-regulation of Fas ligand and apoptosis of T lymphocytes are associated with islet graft tolerance. Transplantation (2001) 1.38

Depletion of T-cell subpopulations results in exacerbation of myocarditis and parasitism in experimental Chagas' disease. Infect Immun (1994) 1.38

SZGR: a comprehensive schizophrenia gene resource. Mol Psychiatry (2010) 1.36

Zearalenones: characterization of the estrogenic potencies and receptor interactions of a series of fungal beta-resorcylic acid lactones. Endocrinology (1979) 1.36

Where is the sun? Nat Neurosci (1998) 1.36

Transcription activation by the human estrogen receptor subtype beta (ER beta) studied with ER beta and ER alpha receptor chimeras. Endocrinology (1998) 1.36

Positron emission tomography with 2-[18F]Fluoro-2-deoxy-D-glucose and 16alpha-[18F]fluoro-17beta-estradiol in breast cancer: correlation with estrogen receptor status and response to systemic therapy. Clin Cancer Res (1996) 1.35

The geranylgeranyltransferase-I inhibitor GGTI-298 arrests human tumor cells in G0/G1 and induces p21(WAF1/CIP1/SDI1) in a p53-independent manner. J Biol Chem (1997) 1.35

Efficient extraction and partial purification of the polyribosome-associated stem-loop binding protein bound to the 3' end of histone mRNA. Biochemistry (1996) 1.35

Positron tomographic assessment of estrogen receptors in breast cancer: comparison with FDG-PET and in vitro receptor assays. J Nucl Med (1995) 1.34

Prepaid versus traditional Medicaid plans: lack of effect on pregnancy outcomes and prenatal care. Health Serv Res (1991) 1.34